Echo Therapeutics, Inc. (ECTE)
-NasdaqCM 2.62 
0.12(4.38%) Jun 19, 4:00PM EDT|After Hours
:
2.67 0.05 (1.91%) Jun 19, 5:51PM EDT
| Prev Close: | 2.74 |
|---|
| Open: | 2.75 |
|---|
| Bid: | 2.64 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 19.67 |
|---|
| Beta: | 1.1 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 2.58 - 2.78 |
|---|
| 52wk Range: | 1.80 - 18.90 |
|---|
| Volume: | 356,680 |
|---|
| Avg Vol (3m): | 96,980 |
|---|
| Market Cap: | 15.80M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -3.77 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the UnderwriterPR Newswire(Wed, Jun 19)
- ECHO THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Wed, Jun 19)
- Echo Therapeutics: A Gross Disregard To Shareholder Valueat Seeking Alpha(Mon, Jun 17)
- Echo Therapeutics 4.025M share Secondary priced at $2.70theflyonthewall.com(Thu, Jun 13)
- Echo Therapeutics Announces Pricing of Public Offering of Common StockPR Newswire(Thu, Jun 13)
- ECHO THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon, Jun 10)
- Echo Therapeutics Submits Pre-Submission Package to FDA for Symphony® CGM SystemPR Newswire(Mon, Jun 10)
- ECHO THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Fri, Jun 7)
- Echo Therapeutics Announces Reverse Split of Common StockPR Newswire(Thu, Jun 6)
- Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony® CGM SystemPR Newswire(Wed, Jun 5)
- Echo Therapeutics to Present at the Jefferies Global Healthcare ConferencePR Newswire(Thu, May 30)
- Notified Body Accepts Echo Therapeutics' Clinical Trial Plan for Symphony® CGM SystemPR Newswire(Wed, May 29)
- ECHO THERAPEUTICS, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders, Financial StatemenEDGAR Online(Tue, May 28)
- Echo Therapeutics Announces Successful Unveiling of Symphony® CGM SystemPR Newswire(Thu, May 23)
- ECHO THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial StatementsEDGAR Online(Thu, May 23)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -3.44 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.81 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | -0.02 |
|---|
Business Summary
Echo Therapeutics, Inc. operates as a transdermal medical device company in the United States. The company is involved in developing Prelude SkinPrep System, which is a platform technology to allow painless skin permeation that would enable both n...
View More